Skip to Content

Pfizer/Allergan deal pushes 2015 into the record books

Pfizer In Merger Talks With Allergan PLCPfizer In Merger Talks With Allergan PLC
Pfizer's HQ in New YorkPhotograph by Spencer Platt—Getty Images

2015 is now officially a record year for global mergers and acquisitions, following this morning’s mega-merger announcement between Pfizer Inc. (PFE) and Allergan (AGN).

Thomson Reuters reports that global M&A stands at $4.2 billion, besting the previous top of $4.1 billion from 2007 (i.e., just before the financial crisis). It is only the second time in history that there has been more than $4 billion in M&A activity, and the threshold was crossed earlier in 2015 than in 2007. Moreover, 2015 also has played host to a record-breaking number of deals valued at $5 billion or more.

Source: Thomson Reuters

It also is worth noting that the Pfizer/Allergan combination would be the second-largest merger on record, following Vodafone Airtouch’s $202.8 billion purchase of Mannesmann in 1999. It also helps further obliterate existing pharma and healthcare M&A stats:

Source: Thomson Reuters
Dan Primack

Get Term Sheet, our daily newsletter on deals & deal-makers.